Steroid hormone treatment for Kawasaki disease in children

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Jones, Katie S ^a   Baumer, J Harry ^b   Gupta, Amit ^c   Dua, Jaspal S ^d  

^a ROYAL COLLEGE OF PAEDIATRICS AND CHILD HEALTH   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IMMUNOGLOBULIN; PLACEBO; STEROID;

CLINICAL TRIAL; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HEMATOLOGICAL PARAMETERS; HUMAN; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; PREVALENCE; REVIEW; STEROID THERAPY; SYSTEMATIC REVIEW;

EID: 55049106709     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003284.pub2     Document Type: Review

References (22)

1. AHAC 1990 American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Diagnostic guidelines for Kawasaki disease. American Journal of Diseases of Children 1990;144(11):1218-9.
2. Bronstein 1997 Bronstein DE, Besser RE, Burns JC. Passive surveillance for Kawasaki disease in San Diego County. Pediatric Infectious Diseases Journal 1997;16(11):1015-8.
3. Burns 1984 Burns JC, Glode MP, Clarke SH, Wiggins J Jr, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. Journal of Pediatrics 1984;105(2):206-11.
4. Furusho 1984 Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya, Hayashidera T, et al.High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2(8411):1055-8.
5. Kato 1979 Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary involvement. Pediatrics 1979;63(2):175-9.
6. Kawasaki 1967 Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Japanese Journal of Allergy 1967;16(3):178-222.
7. Kawasaki 1974 Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54(3):271-6.
8. Kijima 1982 Kijima Y, Kamiya T, Suzuki A, Hirose O, Manabe H. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Japanese Circulation Journal 1982;46(11):1239-42.
9. Mantel 1959 Mantel N, Haenszel W. Statistical aspects of the analysis of data from restrospective studies of disease. Journal of the National Cancer Institute 1959;22(4):719-48.
10. Morens 1980 Morens DM, Anderson LJ, Hurwitz ES. National surveillance of Kawasaki disease. Pediatrics 1980;65(1):21-5.
11. Newburger 1986 Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al.The treatment of Kawasaki syndrome with intravenous gamma globulin. New England Journal of Medicine 1986;315(6):341-7.
12. Niwa 1995 Niwa K, Aotsuka H, Hamada H, Uchishiba M, Terai M, Niimi H. Thrombocytopenia: a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease. Coronary Artery Disease 1995;6(11):857-64.
13. Oates-Whitehead 2003 Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al.Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: DOI: 10.1002/14651858. CD004000CD004000]
14. Shinobara 1996 Shinobara M, Sone K, Tabata H, Kobayashi T, Kosuda T, Robayashi T, et al.Assessment of drug therapy with aspirin, prednisolone, gammaglobulin and these combinations for the acute stage of Kawasaki disease. Kitakanto Medicine Journal 1996;16:249-66.
15. Shinobara 1999 Shinobara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of acute phase of Kawasaki disease. Journal of Pediatrics 1999;155:465-9.
16. Shulman 1999 Shulman ST. High-dose aspirin in Kawasaki disease. Journal of Pediatrics 1999;134(4):523-4.
17. Taubert 1991 Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. Journal of Pediatrics 1991;119(2):279-82.
18. Taubert 1994 Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatric Infectious Disease Journal 1994;13(8):704-8.
19. Umezawa 1992 Umezawa T, Matsuo N, Saji T. Treatment of Kawasaki disease using the intravenous aspirin anti-inflammatory effect of salicylate. Acta Paediatrica Japonica 1992;34(6):548-8.
20. Wright 1996 Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of inmmune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. Journal of Pediatrics 1996;128(1):146-9.
21. Yanagawa 1995 Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Archives of Pediatrics & Adolescent Medicine 1995;149(7):779-83.
22. Liu 2001 Liu H, Zhou T, Wang X. Steroid hormone treatment for Kawasaki disease in children. Cochrane Database of Systematic Reviews 2001, Issue 4. [CENTRAL: CD003284; DOI: 10.1002/14651858]